Anemia and fatigue in cancer patients
- 15 September 2001
- Vol. 92 (S6) , 1719-1724
- https://doi.org/10.1002/1097-0142(20010915)92:6+<1719::aid-cncr1503>3.0.co;2-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietinAmerican Journal of Kidney Diseases, 1996
- Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapyCancer, 1995
- Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patientsAmerican Journal of Kidney Diseases, 1995
- Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.Archives of Disease in Childhood, 1993
- National Cooperative rHu Erythropoietin Study in Patients With Chronic Renal Failure—An Interim ReportAmerican Journal of Kidney Diseases, 1993
- Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination ChemotherapyJNCI Journal of the National Cancer Institute, 1993
- Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine TherapyAnnals of Internal Medicine, 1992
- The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietinControlled Clinical Trials, 1991
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989